Can We Improve the Monitoring of People With Multiple Sclerosis Using Simple Tools, Data Sharing, and Patient Engagement?

Technological innovation is transforming traditional clinical practice, enabling people with multiple sclerosis (pwMS) to contribute health care outcome data remotely between clinic visits. In both relapsing and progressive forms of multiple sclerosis (MS), patients may experience variable disabilit...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in neurology Vol. 11; p. 464
Main Authors Allen-Philbey, Kimberley, Middleton, Rod, Tuite-Dalton, Katie, Baker, Elaine, Stennett, Andrea, Albor, Christo, Schmierer, Klaus
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 12.06.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Technological innovation is transforming traditional clinical practice, enabling people with multiple sclerosis (pwMS) to contribute health care outcome data remotely between clinic visits. In both relapsing and progressive forms of multiple sclerosis (MS), patients may experience variable disability accrual and symptoms throughout their disease course. The potential impact on the quality of life (QoL) in pwMS and their families and carers is profound. The introduction of treatment targets, such as NEDA (no evidence of disease activity) and NEPAD (no evidence of progression or active disease), that guide clinical decision-making, highlight the importance of utilizing sensitive instruments to measure and track disease activity and progression. However, the gold standard neurological disability tool—expanded disability severity scale (EDSS)—has universally recognized limitations. With strides made in our understanding of MS pathophysiology and DMT responsiveness, maintaining the status quo of measuring disability progression is no longer the recommended option. Outside the clinical trial setting, a comprehensive monitoring system has not been robustly established for pwMS. A 21st-century approach is required to integrate clinical, paraclinical, and patient-reported outcome (PRO) data from electronic health records, local databases, and patient registries. Patient and public involvement (PPI) is critical in the design and implementation of this workflow. To take full advantage of the potential of digital technology in the monitoring and care and QoL of pwMS will require iterative feedback between pwMS, health care professionals (HCPs), scientists, and digital experts.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Neurorehabilitation, a section of the journal Frontiers in Neurology
Reviewed by: Antonio Carotenuto, University of Naples Federico II, Italy; Nevin John, University College London, United Kingdom
Edited by: Marcello Moccia, University of Naples Federico II, Italy
ISSN:1664-2295
1664-2295
DOI:10.3389/fneur.2020.00464